Αρχειοθήκη ιστολογίου

Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174

Σάββατο 3 Δεκεμβρίου 2016

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis

Adding mepolizumab to standard treatment with inhaled corticosteroids and controller medications could decrease asthma exacerbations and use of long-term oral steroids in patients with severe disease and increased eosinophils; however, mepolizumab is costly and its cost effectiveness is unknown.

http://ift.tt/2fXPAge

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου